The cytotoxic effects of ibrutinib were enhanced in vitro by the presence of inhibitors targeting breast cancer resistance protein, encoded by ABCG2, and P-glycoprotein, P-gp, encoded by ABCB1 [10]. The gene discussed is ABCB1; the disease is breast carcinoma.